BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 89 filers reported holding BICYCLE THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $787,528 | +23.4% | 39,200 | +56.8% | 0.01% | +44.4% |
| Q2 2023 | $638,000 | -43.6% | 25,000 | -53.0% | 0.01% | -43.8% |
| Q1 2023 | $1,131,564 | -45.5% | 53,200 | -24.2% | 0.02% | -42.9% |
| Q4 2022 | $2,077,920 | -8.9% | 70,200 | -28.4% | 0.03% | -15.2% |
| Q3 2022 | $2,282,000 | +61.2% | 98,100 | +16.2% | 0.03% | +65.0% |
| Q2 2022 | $1,416,000 | -11.6% | 84,400 | +131.2% | 0.02% | +5.3% |
| Q1 2022 | $1,602,000 | -51.0% | 36,500 | -32.0% | 0.02% | -44.1% |
| Q4 2021 | $3,269,000 | +19.7% | 53,700 | -18.3% | 0.03% | +21.4% |
| Q3 2021 | $2,732,000 | – | 65,700 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |